LifeBridge Innovations, PBC

Transforming metastatic cancer from a terminal prognosis to a manageable disease like diabetes

https://wefunder.com/LifeBridgeinnovations

Total raised on Wefunder: 368836

Total investors: 217

Quick facts

  • Team has 60 devices through FDA, products in 3000 hospitals, 300 yrs combined experience
  • Med tech firm sent unsolicited offer to buy us -investor/team unanimously agreed too early to sell
  • Granted patents in U.S., Canada, MX, EU, Japan, China, Australia, New Zealand, India, Chile
  • $5M raised from friends & family, angels, who know our track record & see a huge market opportunity
  • TTF is based on 25 years of proven research. Fixed form approved by the FDA for multiple indications
  • On any given day, over 500,000 U.S. patients in their last 36months could benefit from our therapy
  • TTF has minimal side effects: no hair loss, no nausea, no fatigue, no chemo brain, etc.
  • Committed to serve those who cannot afford it while maintaining industry benchmarked profitability

Team profiles

Featured investor profiles

LifeBridge Innovations, PBC

Transforming metastatic cancer from a terminal prognosis to a manageable disease like diabetes

Funded badge
Last Funded January 2026

$3,960,158

raised from 217 investors
Pitch Video
Investor Panel

Investor Panel

Shu interviewed LifeBridge Innovations, PBC on July 26, 2021. Play Video
Shu Li
Shu Li
CEO and co-founder of Petri-Bio
Strengths
says, "This company is creating a solution for patients that basically running out of options. They are really tackling an extremely challenging problem and also finding hope for these families. The founders are very mission-driven and have first-hand experience. I do hope they can succeed in their startup journey"
Advice
says, "I think the regulatory model for this particular device might be different than a typical drug due to the unique patients groups, if so, it'd help the audience better understand your path by explaining it in more details"

What Investors Say

LEAD INVESTOR
Invested $10,000 this round + $189,650 previously
The LifeBridge Innovations patented Adaptive Tumor Treating Fields (ATTF) technology is a significant improvement on the Novocure (Nasdaq: NVCR) Tumor Treating Fields (TTF) technology. It was designed to treat metastatic cancer. There are 25 million people world-wide and 500,000 Americans who have exhausted all other treatments. ATTF has the potential to significantly extend their lives without the standard side effects of chemotherapy or radiation. Please study LifeBridge to see if you would be willing to join me in helping them extend the lives of metastatic cancer patients.

What Friends Say

What People Say